Stay updated with breaking news from Jens Holstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low...
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating...
Investegate announcements from BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
By Helena Smolak BioNTech swung to a net loss in the first quarter on plummeted revenue after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on the...
BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by innovative R&D and strong cash reserves.